ReShape Lifesciences Inc. announced the appointment of Michael Bordainick as its Senior Vice President, Commercial Operations. In this newly created role, as part of the Company's next phase of operational growth, Mr. Bordainick will be responsible for strengthening the strategic development and executional efficiencies of the sales and marketing teams. He joins Reshape from Alcon, where he served as Global Vice President of Marketing, responsible for marketing and sales activities of the company's $1.8 billion contact lens portfolio.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.188 USD | +4.44% | -10.86% | -24.71% |
15/05 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.71% | 4.41M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.70% | 65.19B | |
+15.38% | 53.02B | |
+3.64% | 50.28B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- ReShape Lifesciences Inc. Appoints Michael Bordainick as Senior Vice President, Commercial Operations